AJP - Renal AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (July 30, 2002). doi:10.1152/ajprenal.00040.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/6/F1313    most recent
00040.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, W.
Right arrow Articles by Nielsen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, W.
Right arrow Articles by Nielsen, S.

Articles in PresS, published online ahead of print July 30, 2002
Am J Physiol Renal Physiol, 10.1152/ajprenal.00040.2002
Submitted on January 29, 2002
Accepted on July 23, 2002

AQP3, p-AQP2 and AQP2 expression is reduced in polyuric rats with hypercalcemia: prevention by cAMP-PDE inhibitors

Weidong Wang1, Chunling Li2, Tae-Hwan Kwon1, Mark A. Knepper3, Jorgen Frokiaer2, and Soren Nielsen1*

1 The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark; Department of Physiology, Dongguk Univ, Kyungju, Korea, Republic
2 The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark; Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
3 Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA

* To whom correspondence should be addressed. E-mail: sn{at}ana.au.dk.

The purpose of this study was to evaluate whether hypercalcemia (HC) is associated with downregulation of renal aquaporins, including AQP1, AQP2, phosphorylated-AQP2, AQP3, and AQP4, and if this is the case to test whether cAMP-phosphodiesterase inhibitor treatment can prevent AQP downregulation and prevent the development of polyuria. Vitamin-D-induced HC in rats was associated with increased urine output and reduced urine osmolality, consistent with previous findings (20). Semiquantitative immunoblotting revealed a significant reduction in the abundance of inner medullary AQP2 (52±6% of control levels), consistent with previous studies, and of AQP2 which is phosphorylated at the PKA phosphorylation consensus site serine 256 (p-AQP2; 36 ± 8%). Moreover, AQP3 abundance was also significantly decreased (45 ± 7% and 61 ± 6% of control levels in inner medulla and whole kidney, respectively). Consistent with this, immunohistochemistry demonstrated reduced AQP3 immunolabeling along the entire collecting duct. AQP4 expression was not reduced. Surprisingly, total kidney AQP1 abundance was also reduced (60 ± 6%). AQP1 expression was reduced in cortex and outer stripe of the outer medulla (48 ± 7%; i.e. in proximal tubules). In contrast, AQP1 levels were not changed in inner stripe of the outer medulla or in inner medulla (i.e. descending thin limbs and vasa recta). Treatment with the cAMP-phosphodiesterase inhibitors rolipram and milrinone in combination (inhibiting PDE-IV and III isoenzymes) at day two and onwards completely prevented the HC-induced downregulation of AQP2 and AQP3 (but not AQP1) and completely prevented the development of polyuria. In conclusion: AQP3, AQP2, and p-AQP2 is downregulated and are likely to play critical roles in the development of polyuria associated with vitamin-D induced HC. Moreover, PDE inhibitor treatment significantly prevented the reduced expression of collecting duct AQPs and prevented the development of polyuria.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
X. Wang, P. C. Harris, S. Somlo, D. Batlle, and V. E. Torres
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 526 - 534.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Bustamante, U. Hasler, V. Leroy, S. de Seigneux, M. Dimitrov, D. Mordasini, M. Rousselot, P.-Y. Martin, and E. Feraille
Calcium-sensing Receptor Attenuates AVP-induced Aquaporin-2 Expression via a Calmodulin-dependent Mechanism
J. Am. Soc. Nephrol., January 1, 2008; 19(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. H. Robben, N. V. A. M. Knoers, and P. M. T. Deen
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F257 - F270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. Yang, D. Zhao, L. Qian, and A. S. Verkman
Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F465 - F472.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. W. McDill, S.-Z. Li, P. A. Kovach, L. Ding, and F. Chen
Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation
PNAS, May 2, 2006; 103(18): 6952 - 6957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Bustamante, U. Hasler, O. Kotova, A. V. Chibalin, D. Mordasini, M. Rousselot, A. Vandewalle, P.-Y. Martin, and E. Feraille
Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells
Am J Physiol Renal Physiol, February 1, 2005; 288(2): F334 - F344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Wang, C. Li, T.-H. Kwon, R. T. Miller, M. A. Knepper, J. Frokiaer, and S. Nielsen
Reduced expression of renal Na+ transporters in rats with PTH-induced hypercalcemia
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F534 - F545.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.